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Abstract
Background and Aims: Acute renal failure is a 
relevant complication in obstructive jaundice (OJ). 
The extracellular water volume (ECW) depletion and 
myocardial dysfunction affects haemodynamic and renal 
disturbance in patients with OJ. Methods: A prospective 
open randomised study was conducted to evaluate the 
effect of peridrainage saline infusion associated with 
dopamine administration on hormonal and renal function 
derangements in 102 patients with malignant OJ. Patients 
were randomly distributed according to whether (n=64) or 
not (n=38) received dopamine with saline solution before 
endoscopic biliary drainage. Furthermore, patients receiving 
dopamine were randomly distributed whether (n=31) or 
not (n=33) received additional dopamine administration 
during the postdrainage phase. Different parameters such as 
ECW, serum levels of aldosterone, renin, atrial natriuretic 
peptide (ANP), antidiuretic hormone (ADH), endothelin-1 
(ET-1), urine PGE2 and creatinine clearance (CrCl) were 
analyzed. Results: Fluid administration was accompanied 
by an increase in the ECW (p=0.01) and an improvement 
in the CrCl (p=0.01). Dopamine increased CrCl by 11% 
(p=0.04) and reduced urinary PGE2 concentration (p=0.02). 
After drainage, a transient worsening of CrCl was seen in 
patients on i.v. fluid infusion alone but not in dopamine 
groups (p=0.001). Improvement of CrCl after dopamine 
administration was found in patients with serum bilirubin 
> 16 mg/dl and sodium urine excretion <145 mEq/l. 
Conclusions: The administration of dopamine associated 
with appropriate i.v. fluid infusion in the peridrainage period 
has an impact on renal function only in selected patients with 
malignant biliary obstruction. This effect is more relevant 
in patients with higher marked cholestasis. 
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Introduction
The association between obstructive jaundice (OJ) and 
renal failure has been recognized since 1910 when Clairmont 
[1] reported the development of acute renal failure, with 
subsequent death, in five patients following surgery for OJ. 
Although the aetiology of renal dysfunction is multifactorial 
[2], it is strongly associated with haemodynamic and body 
fluid disturbances [2-5]. The presence of extracellular 
fluid (ECW) depletion [6-8] and myocardial dysfunction 
[9, 10] has been recently pointed out to be relevant for 
haemodynamic and renal disturbances in patients with OJ. 
Moderate volume depletion has been observed in these 
patients measured by tracer dilution techniques [6] and 
endocrine markers such as renin plasma levels [11-15]. 
The administration of intravenous (i.v.) fluids expands the 
ECW in the perioperative period. However, this strategy 
has been shown to fail in improving renal function in 30% 
of patients [16]. This suggests that other active sodium and 
water balance regulatory hormones, such as endothelin-1 
(ET-1) may also play a role during perioperative renal failure 
[17, 18]. Volume depletion is related to a rise in ET-1 blood 
concentration which causes renal vasoconstriction and a 
reduction of the glomerular filtration rate. This might explain 
the compensatory elevation of urinary PGE2 observed in 
these patients [19].
The addition of a renal vasodilator agent such as dopamine 
could counteract the renal vasoconstriction associated with 
ET-1 activity. This effect of dopamine has been observed in 
experimental studies of chronic OJ [20]. The administration 
of dopamine during postoperative period has not showed any 
significant improvement of renal function in patients with 
perioperative renal dysfunction [7, 21]. However, the effect 
of dopamine administered before biliary drainage or surgery 
in patients with OJ on the renal and endocrine derangements 
has not been assessed. The present study was therefore 
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designed to analyse the effect of dopamine associated with 
fluid administration on ECW, water and sodium regulating 
hormones and renal function alterations in patients with OJ 
undergoing endoscopic internal biliary drainage.
Methods
Design 
The study was designed as a prospective, open, 
randomised trial including patients with malignant OJ, a 
bilirubin concentration higher than 6 mg/dl, ultrasound 
evidence of extrahepatic and intrahepatic bile duct dilation 
(more than 8 mm and 4 mm, respectively) and feasibility of 
internal endoscopic biliary drainage. The exclusion criteria 
were cholangitis, acute pancreatitis, heart disease, arterial 
hypertension, chronic lung disease, use of diuretics and 
chronic renal failure. The informed consent was obtained 
from all patients as well as permission to publish the results 
of the investigation. The study was approved by the Hospital 
Clinical Trials and Ethics Committee. The registration 
number of the clinical trial was ISRCTN14198655.
Patients
One hundred and two patients with malignant OJ were 
randomly distributed in two treatment groups according to 
whether they had (n=64) or not (n=38) received dopamine (3 
µg/Kg/min) associated with saline solution infusion (45 ml/
kg) for 48 hours before biliary drainage (Fig. 1). The patients 
receiving dopamine before biliary drainage were additionally 
randomly distributed according to whether they had (n=31) 
or not (n=33) received dopamine 72 h after postdrainage 
intervention. The patients without dopamine administration 
(n=38) did not receive dopamine administration after 
postdrainage intervention. The endoscopic biliary drainage 
was unsuccessful in 8 patients. Therefore, the postdrainage 
study groups (total n= 94) included patients with fluid infusion 
(n=35), fluid and dopamine predrainage administration (n=31) 
and fluid and dopamine (pre and postdrainage) administration 
(n=28) (Fig. 1). All patients were  maintained under the same 
conditions. The patients were fasted for the first 12 h after 
endoscopic internal drainage, and then  administrated with 
2.5 l of glucosaline solution containing 150 mEq of NaCl 
until the following morning. On the second day, the i.v. 
Fig 1. CONSORT flow diagram
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infusion was stopped and patients received a 2000 kcal/day 
diet up to the 72 h when the study protocol was terminated. 
The sodium content of the diet was 80 mEq/day and a free 
fluid intake was allowed. 
The endoscopic biliary drainage was considered 
successful if total bilirubin decreased around 30% and the 
size of the common bile duct diameter was significantly 
reduced by ultrasound 72 h after surgical intervention. The 
metallic self-expandable endoprosthesis (Wallstent®: 30 
Fr) and plastic endoprosthesis (10 Fr) were implanted in 
41 and 53 patients, respectively. Biochemical, hormonal 
and bioelectrical impedance analysis were performed at 
admission, before drainage, as well as 24 h and 72 h after 
biliary drainage.  
Parameters analysed
Creatinine clearance (CrCl) was measured by the 
Modification of Diet in Renal Disease (MDRD) formula 
[22]. ECW was determined by bioelectrical impedance 
using a BIA-101S analyser (RJL System Inc MT Clemens 
MI USA) with the prediction equation of Lukaski and 
Bolonchuck [23]. All bioimpedance measurements were 
performed by the same experienced observer and ECW was 
reported as a percentage of body weight. The concentration 
of hormones was determined in the plasma. Blood was 
collected into chilled tubes containing EDTA (2 mg/ml) 
and aprotinin (Trasylol 400 KIU/ml, Sigma Chemical Co, 
St. Louis, MO, USA), and centrifuged at 3.000 rpm at 4oC 
for 10 min within 30 min of collection. The plasma was 
obtained and stored frozen at –70oC until measurements. 
The concentration of ANP (h-ANP, Cob. I-AR55 Co. Ltd., 
Tokio, Japan), endothelin-1 (RIA, Peninsula Laboratories 
Inc. RIK-6901 Human endothelin-1, California USA), renin 
(a-Renin IRMA 4K-REN-00, Future Diagnostics, Witjchen, 
The Netherlands), aldosterone (RIA DSL-8600 ACTIVETM 
Diagnostic Systems Laboratories, Inc. Webster, Texas; 
USA) and  vasopressin (RIA , Península Laboratories Inc., 
cod. Rik-8 103 [Arg8]-Vasopressin, California,USA) was 
determined using commercial radioimmunoassay. The data 
was recorded by a γ-scintillator (Ultrogamma Counter-Ina, 
Crystal 2-5400 B-5412; Packard Instrument Company Inc., 
Canberra, Australia). The concentration of PGE2 in urine 
was measured by a commercial ELISA test (Rand D Systems 
Inc. Minneapolis, MN 55413, USA).
Statistical methods 
The sample size was estimated on the assumption of 5% 
improvement on renal function after dopamine treatment 
[16]. Thus, a minimum of 21 patients  was  required in each 
group (bilateral contrast with α error <5% and power of 95%; 
n2/n1=1). Results are expressed as mean ± SD with 95% 
confidence intervals. The inter- and intra-group statistical 
analysis was carried out using the two-tailed Student’s t test 
for unpaired and paired data. ANOVA for repeated measures 
and Newman-Keuls test were also used for post-drainage 
analysis. The statistical significance was set at p<0.05. 
The correlation of variables was assessed using Pearson’s 
coefficient. The multivariate analysis was performed to 
determine factors that might predict an improvement in 
renal function after dopamine administration. CrCl was 
used as dependent variable. Variables for which p > 0.1 
were excluded from the regression study using the stepwise 




The study group included 94 patients with malignant OJ 
with the presence of periampullary tumours (n=47), pancreatic 
cancer (n=35), ampuloma (n=12), cholangiocarcinomas 
(n=34) and gallbladder tumours (n=13). The study included 
men (n=33, 33%) and women (n=61, 67%) with a mean age 
of 71±8.8 years (range 35-76). The mean duration of jaundice 
was 14±8 days. The three groups were well matched for the 
most significant variables of the study (Table I).


























Renin (µg/L) 0.042±0.01 0.045±0.02 0.046±0.03
ADH  (ng/L) 16±4 15±5 16±6
ET-1 (pg/ml) 17.7 ±1.4 17.1±2 18±1.6
PGE2 (pg/L) 21113±735 20856±670 20930±710










*Unpaired Student’s t test. Newman-Keuls; ANP: atrial natriuretic 
peptide; ADH: antidiuretic hormone; ET-1: endothelin-1; PGE2: 
prostaglandin E2; CrCL: creatinine clearance; ECW: extracellular
Pre-drainage study
The administration of fluid was accompanied by an 
increase in the ECW, diuresis, ANP levels and improvement 
of CrCl (Table II). The patients who received dopamine 
associated with fluid administration prior to drainage showed 
a significant improvement in CrCl accompanied by decrease 
in PGE2 concentration and an increase of urinary sodium 
164 Naranjo et al
excretion. Neither the ECW nor plasma renin showed 
significant changes (Table II).
Post-drainage study
The concentration of bilirubin, ANP, aldosterone and 
ET-1 in plasma levels, as well as PGE2 levels in urine 
showed a significant reduction after drainage (Table III). In 
patients treated only with saline administration, a transient 
impairment of CrCl was seen 24 h after drainage, but not 
in dopamine groups. There were no differences in CrCl 
between dopamine-treated groups. The proportion of CrCl 
determinations which showed a baseline 10% improvement 
was 69% in the group of fluid therapy alone versus 84% 
in the dopamine group pre-drainage (p=0.03) and 81% in 
patients with pre and post-drainage dopamine (p=0.03), 
respectively.
Multivariate analysis 
Serum bilirubin (p=0.003) and urinary sodium excretion 
(p=0.01) proved to be reliable predictors of good response 
in renal function after treatment with dopamine in patients 
with OJ (Table IV). The logistic equation obtained for renal 
function was: CrCl increase (%): 0.31 + 0.90 (bilirubin) - 
0.04 (urinary sodium excretion) 
The sensitivity and specificity of the equation to detect 
renal dysfunction were 81% and 87%, respectively. Positive 
(bilirubin) and negative (urinary sodium excretion) predictive 
values of the equation were 87% (95% confidence interval 
= 74-96%) and 75% (95% confidence interval = 67-84%), 
respectively. The administration of dopamine increased 
greater  than 10% CrCl in patients with baseline bilirubin 
>16 mg/dl and urinary sodium excretion <145 mEq/L. 
Discussion
Patients with OJ frequently suffer haemodynamic and 
body fluid disturbances [3-5]. It has been shown that ECW 
is reduced in the presence of biliary obstruction when 
compared with healthy subjects [7-9]. In the present study, 
dopamine administration associated with i.v. fluid infusion 
prior to biliary drainage led to an improvement in renal 
function in selected patients with malignant OJ. This effect 
of dopamine  was prolonged after endoscopic internal biliary 
drainage. These findings are relevant for the peri-drainage 
management of OJ patients, especially when some degree 
of renal dysfunction is detected.
Cholestatic patients showed a paradoxical increase of 
ANP plasma concentrations, and renin and aldosterone in 
the normal-high range suggesting a marginal reduction of 
plasma volume [6-13]. This reduction of plasma volume has 
been previously associated with hemodynamic changes [10, 
24, 25]. Part of the volume depletion in obstructive jaundice 
is due to an increase in sodium taurocholate, which has a 
natriuretic property [26]. It may be speculated that this may 
limit ascites accumulation in patients with biliary cirrhosis 
in striking contrast to patients with alcoholic cirrhosis. The 
reduction of plasma volume is commonly associated with 
hypoalbuminemia in malignant OJ [14]. These changes 
cannot be ascribed to malnutrition [27], because in protein 
and fat nutritional deficiency a relative expansion, but not 
reduction of the ECW, is observed [28]. 
The administration of normal saline the day before 
biliary drainage improved the CrCl increased diuresis and 
corrected the ECW deficit. The infusion volume is related to 
the magnitude of ECW depletion in patients with two to three 
weeks of OJ duration [14]. Previous studies have attributed 
the preservation of renal function mostly to the benefits of 
a pre-procedural intravenous volume expansion [7, 21]. The 
renal functional improvement is transient and restricted to the 
duration of fluid infusion as a consequence of the lack of the 
beneficial effect on CrCl of the fluid expansion in a relevant 
proportion of patients (30%) either after drainage or post-
operative recovery of renal function [18]. These data suggest 
that other sodium and water content regulatory hormones, 




















































































*Paired Student’s t test: (a): p=0.001 with baseline; (b): p=0.01 with 
baseline; (c): p=0.03 with baseline;  (d): variation: p=0.02 with fluid 
infusion alone;  (e) variation: p=0.04 with fluid infusion alone
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such as endothelin-1 (ET-1) [17] also play a role as a final 
mediator of perioperative renal failure. When volume 
depletion is observed, as occurs in obstructed patients, the 
increase of ET-1 activity is often detected associated with 
renal vasoconstriction and reduced glomerular filtration rate. 
This situation is compatible with the compensatory elevation 
of PGE2 in urine [19]. The release of dopamine induces renal 
vasodilatation that may counteract the renal vasoconstriction 
associated with ET-1. This has been demonstrated in 
experimental models of long term OJ [20]. The present 
study showed that patients receiving dopamine with fluid 
table III. Comparison of different parameters during post-drainage in patients with and without 
dopamine associated with intravenous fluid therapy
Pre-drainage 24 h 72 h
         P*
Intra           Inter
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0.01               0.01
0.01
NS: not significant. Newman-Keuls test:  a:p<0.05 with pre-drainage, b:p<0.01 with pre-drainage; 
c:p<0.001 with pre-drainage; ANP: atrial natriuretic peptide; ADH: antidiuretic hormone; ET-1: 
endothelin-1; PGE2: prostaglandin E2; CrCL: creatinine clearance; ECW: extracellular
pre-drainage administration demonstrated a significant 
improvement in CrCl accompanied by an increase of urinary 
sodium excretion and a decrease in PGE2 concentration in 
urine, indicating an inhibition of prostaglandin secretion. The 
group treated only with fluid administration did not show any 
evidence of an increase in ECW and diuretic response.
It has been previously observed that the administration of 
dopamine during the perioperative period failed to improve 
renal function in patients with OJ [7, 21]. These studies, 
however, were performed only during the postoperative 
period in a small series of patients with significant dispersion 
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of data. In the present study, patients under fluid therapy 
alone presented a transient decrease in CrCl 24 hours after 
biliary drainage. This impairment was not found in the 
dopamine-treated group. This may be related to better pre-
drainage recovery of glomerular filtration, facilitated by 
the administration of dopamine, counteracting the effects 
of potential release of late kidney damaging mediators. 
Moreover, the percentage of CrCl determinations which 
improved by 10% or more after the restoration of duodenal 
bile flow compared to baseline, was higher in patients with 
dopamine administration. 
In order to select patients which would benefit from 
the administration of dopamine associated with volume 
replacement, a multivariate analysis was performed that 
showed that dopamine would be especially useful in patients 
with higher serum bilirubin levels and lower urinary sodium 
excretion. This assumption would support the hypothesis 
that dopamine is more beneficial in patients with increased 
activity of ET-1 in whom urinary sodium elimination is 
markedly reduced.
Conclusion 
The administration of dopamine associated with 
appropriate fluid infusion may be included in the management 
of renal dysfunction of selected patients with malignant OJ 
under endoscopic biliary drainage, especially during the 
pre-drainage period.
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